StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) income statement

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3055% above fair value
$6.91−0.19 (-2.68%)

Close on Nov 19, 2026Market cap $190.73MP/E –Yield –

Precision BioSciences Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-80.8%
Net margin
-117.0%
Return on equity, FY2025
-61.5%

Financial strength

Current ratio
12.82
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1205.5%

Valuation

P/E ratio
–
Price to sales
4.23
Price to book
4.21
Dividend yield
–

See a number that looks wrong?